NCT00031616View on ClinicalTrials.gov

NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer

PHASE1/PHASE2UnknownINTERVENTIONAL
Timeline

Start Date

December 31, 2001

Conditions
Colorectal Cancer
Interventions
DRUG

brivudine phosphoramidate

Trial Locations (2)

90033

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

Sponsors

Lead Sponsor

NewBiotics
All Listed Sponsors
lead

NewBiotics

INDUSTRY

NCT00031616 - NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer | Biotech Hunter | Biotech Hunter